Another study conducted in Sarawak, Malaysia, analyzed blood DNA obtained from 467 patients with BC and revealed pathogenic variants in BRCA1 and BRACA2 in 2.8% and 3.2% of patients, respectively [35]. This evidence concerns the gene BRCA1 and breast cancer.